Related Experiment Video

Updated: Jun 10, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its

Valentina Boni1, Nerea Bitarte, Ion Cristobal

  • 1Oncology Unit, Casa Sollievo Sofferenza, S. Giovanni Rotondo, Italy.

Molecular Cancer Therapeutics
|July 22, 2010
PubMed

Insights

MicroRNAs miR-192 and miR-215 target thymidylate synthase (TYMS) but do not enhance 5-fluorouracil (FU) sensitivity in colorectal cancer. These miRNAs reduce cell proliferation via cell cycle arrest, suggesting alternative mechanisms for FU resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Thymidylate synthase (TYMS) is a key target for fluoropyrimidine chemotherapy in gastrointestinal cancers.
  • TYMS expression is a controversial predictive biomarker for 5-fluorouracil (FU) response in colorectal cancer.
  • MicroRNAs (miRNAs) may influence chemosensitivity, but their role in FU response is not fully understood.

Purpose of the Study:

  • To investigate the role of miR-192 and miR-215 in modulating chemosensitivity to FU in colorectal cancer.
  • To determine if miR-192 and miR-215 target TYMS and affect FU response.
  • To explore the impact of these miRNAs on cell proliferation and cell cycle progression.

Main Methods:

  • In silico analysis followed by experimental validation in colorectal cancer cell lines.
  • Assessment of TYMS expression levels after miRNA overexpression.
  • Evaluation of cell proliferation, cell cycle progression, and protein expression (p53, p21, p27).

Main Results:

  • miR-192 and miR-215 were found to target TYMS expression in colorectal cancer cell lines.
  • Downregulation of TYMS by these miRNAs did not sensitize cells to FU treatment.
  • Overexpression of miR-192/215 reduced cell proliferation by inducing cell cycle arrest, partially mediated by p53 status through p21 and p27 induction.
  • The reduction in S-phase cells by these miRNAs may mitigate the efficacy of S-phase-specific drugs like FU.

Conclusions:

  • miR-192 and miR-215 target TYMS but do not directly enhance FU sensitivity in colorectal cancer.
  • These miRNAs inhibit cell proliferation through cell cycle regulation, independent of TYMS inhibition.
  • Mechanisms other than TYMS overexpression are critical for FU resistance.
  • miR-192/215 may serve as predictive biomarkers for FU response, warranting further investigation.

More Related Videos

Rapid Identification of Chemical Genetic Interactions in Saccharomyces cerevisiae12:13

Rapid Identification of Chemical Genetic Interactions in Saccharomyces cerevisiae

Published on: April 5, 2015

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...